05/11/2026 22:07
|
Medical, Health & Aged Care
* Total global revenues of $1.9 billion for the third quarter, an increase of 34% from the prior year
* BRUKINSA (zanubrutinib) global revenues of $1.4 billion for the third quarter, an increase...